Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Interest Income | 103,237 | 103,778 | 106,654 | 115,209 | 119,492 |
| Interest Expense | 29,494 | 35,171 | 39,219 | 42,114 | 44,602 |
| Interest Income (Net of Interest Expense) | 73,743 | 68,607 | 67,435 | 73,095 | 74,890 |
| Non-Interest Income | 29,982 | 30,782 | 39,658 | 41,228 | 25,297 |
| Sales | 103,725 | 99,389 | 107,093 | 114,323 | 100,187 |
| Credit Losses Provision | 10,000 | 30,000 | 60,892 | 70,781 | 88,556 |
| Non Interest Expenses | 88,308 | 107,530 | 94,223 | 97,315 | 95,977 |
| Pre-tax Income | 5,417 | -38,141 | -48,022 | -53,773 | -84,346 |
| Other Income | 34,911 | -2,970 | -8,803 | -11,659 | -39,744 |
| Net Income | $5,417 | $-38,141 | $-48,022 | $-53,773 | $-84,346 |
| EPS Basic Continuous Ops | 0.09 | 169.62 | -10.08 | -68.24 | -107.04 |
| EPS Basic Total Ops | 0.09 | 126.51 | 7.05 | -73.91 | -112.70 |
| EPS Diluted Continuous Ops | 0.09 | 161.41 | -1.87 | -68.24 | -107.04 |
| EPS Diluted Total Ops | 0.09 | 132.25 | 1.31 | -73.91 | -112.70 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |